Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference

5/22/25 7:30:00 AM ET

Ophthalmic Goods

Health Care

Get the next $BLCO alert in real time by email

Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chief Financial Officer Sam Eldessouky is scheduled to participate in the 2025 Jefferies Global Healthcare Conference in New York City on June 4, 2025, at 7:35 a.m. ET.

A live webcast of the conference will be available on the Investor Relations section of the Bausch + Lomb website.

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,500 employees and a presence in approximately 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250522453039/en/

Media Contact:

Chris Clark

[email protected]

(848) 360-1100

Investor Contact:

George Gadkowski

[email protected]

(877) 354-3705 (toll free)

(908) 927-0735

Get the next $BLCO alert in real time by email

Recent Analyst Ratings for

$BLCO

Date	Price Target	Rating	Analyst
5/2/2025	$20.00 → $15.00	Buy	H.C. Wainwright
3/28/2025	$24.00 → $15.00	Overweight → Equal Weight	Wells Fargo
12/11/2024	$24.00 → $22.00	Buy → Neutral	Citigroup
12/2/2024	$19.00	Overweight → Equal-Weight	Morgan Stanley
10/15/2024	$19.00 → $25.00	In-line → Outperform	Evercore ISI
7/10/2024	$19.00	Outperform	Raymond James
5/6/2024	$16.00 → $18.00	Equal-Weight → Overweight	Morgan Stanley
1/4/2024	$19.00 → $17.00	Outperform → In-line	Evercore ISI

More analyst ratings

Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference

Chat with this insight

Recent Analyst Ratings for
$BLCO

$BLCO
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President, Surgical Bonnefoy Luc covered exercise/tax liability with 968 shares, decreasing direct ownership by 1% to 73,383 units (SEC Form 4)

Director Von Eschenbach Andrew C. was granted 20,338 shares, increasing direct ownership by 49% to 62,086 units (SEC Form 4)

Director Ross Thomas W. Sr. was granted 20,338 shares, increasing direct ownership by 51% to 60,391 units (SEC Form 4)

Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference

Chat with this insight

Recent Analyst Ratings for $BLCO

$BLCO Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President, Surgical Bonnefoy Luc covered exercise/tax liability with 968 shares, decreasing direct ownership by 1% to 73,383 units (SEC Form 4)

Director Von Eschenbach Andrew C. was granted 20,338 shares, increasing direct ownership by 49% to 62,086 units (SEC Form 4)

Director Ross Thomas W. Sr. was granted 20,338 shares, increasing direct ownership by 51% to 60,391 units (SEC Form 4)

Recent Analyst Ratings for
$BLCO

$BLCO
Insider Trading